Concepedia

Fanfei Kong

FK

Statistics

Publications

21

Citations

1.2K

H-Index

18

Active since

2011

Affiliations

China Medical University(Current)

Shanghai First Maternity and Infant Hospital

Huazhong University of Science and Technology

Nanjing Medical University

Tianjin Medical University Cancer Institute and Hospital

Fanfei Kong is an author at China Medical University specializing in medicine, cancer research, and tumor biology.

Top concepts

Publications per year

2011–2023

21

Publications

21

miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint

Shaohua Xu, Zhen Tao, Bo Hai et al. · Nature Communications · 2016 · 283 citations · Full text

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1

Shaohua Xu, Guangbo Fu, Zhen Tao et al. · Oncotarget · 2015 · 103 citations · Full text

LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis

Xin Pan, Da Li, Jianing Huo et al. · Cell Death and Disease · 2018 · 87 citations · Full text

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1

Fanfei Kong, Chaoyang Sun, Zhongxian Wang et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 2011 · 86 citations

, , +9

Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer

Rong Cong, Fanfei Kong, Jian Ma et al. · BMC Cancer · 2020 · 73 citations · Full text

1–5 of 21